trypan blue has been researched along with Acute Confusional Senile Dementia in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kasus-Jacobi, A; Laurence, RB; Pereira, HA; Washburn, JL | 1 |
Cui, W; Tao, T; Wang, C; Wang, Q; Xuan, Z; Yan, S; Yang, M | 1 |
Farrar, CT; Hyman, BT; Koffie, RM; Saidi, LJ; Spires-Jones, TL; William, CM | 1 |
el-Fakahany, EE; Hu, J | 1 |
Butterfield, DA; Koppal, T; Varadarajan, S; Yatin, SM | 1 |
Butterfield, DA; Jahanshahi, F; Kanski, J; Varadarajan, S; Yatin, S | 1 |
Jeong, SJ; Kim, HS; Kim, SS; Lee, JP; Park, CH; Rah, JC; Seo, JH; Suh, YH | 1 |
Chauhan, NB; Lichtor, T; Siegel, GJ | 1 |
8 other study(ies) available for trypan blue and Acute Confusional Senile Dementia
Article | Year |
---|---|
Selecting Multitarget Peptides for Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium-Binding Proteins; Cathepsin G; Humans; Mice; Receptor for Advanced Glycation End Products; Toll-Like Receptor 4; Trypan Blue | 2022 |
CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Cell Line; Cognitive Dysfunction; Cytokines; Humans; Inflammation Mediators; Mice; Mice, Inbred ICR; Microglia; Neurogenic Inflammation; Neurons; NF-kappa B; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; Trypan Blue | 2020 |
Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging.
Topics: Alkaloids; Alzheimer Disease; Animals; Apolipoproteins E; Blood-Brain Barrier; Brain; Contrast Media; Gadolinium; Indoles; Magnetic Resonance Imaging; Mice; Nanoparticles; Optics and Photonics; Photons; Quinolines; Trypan Blue | 2011 |
An artifact associated with using trypan blue exclusion to measure effects of amyloid beta on neuron viability.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Membrane; Cell Survival; Female; Fluoresceins; Hippocampus; Neuroblastoma; Neurons; Rats; Rats, Sprague-Dawley; Trypan Blue; Tumor Cells, Cultured | 1994 |
Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cell Count; Cerebral Cortex; Creatine Kinase; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Free Radicals; Glutamate-Ammonia Ligase; Hippocampus; Humans; Mitochondria; Neurons; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Spin Labels; Synaptosomes; Tetrazolium Salts; Thiazoles; Trypan Blue | 1999 |
Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cells, Cultured; Fetus; Free Radicals; Methionine; Neurons; Neurotoxins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spin Trapping; Tetrazolium Salts; Trypan Blue | 1999 |
Roles of A beta and carboxyl terminal peptide fragments of amyloid precursor protein in Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Brain; Calcium; Electric Conductivity; L-Lactate Dehydrogenase; Lipid Bilayers; Microsomes; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Rats; Sodium-Calcium Exchanger; Trypan Blue; Tumor Cells, Cultured | 2000 |
Distribution of intraventricularly administered antiamyloid-beta peptide (Abeta) antibody in the mouse brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antibodies, Monoclonal; Brain Chemistry; Coloring Agents; Frontal Lobe; Hippocampus; Horseradish Peroxidase; Immunization, Passive; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Microcirculation; Parietal Lobe; Trypan Blue | 2001 |